CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)
- Conditions
- Temporomandibular DisorderBruxismMyofascial PainCBDOrofacial Pain
- Interventions
- Combination Product: 10% polymer gel with CBD applicationCombination Product: 5% polymer gel with CBD applicationCombination Product: Placebo intervention
- Registration Number
- NCT05562635
- Lead Sponsor
- Medical University of Silesia
- Brief Summary
The aim of the project is to assess the effectiveness of reducing the masseter muscles tension and hyperactivity in patients with a painful form of TMD by using polymers containing CBD compared to placebo polymers.
- Detailed Description
Since the healing properties of CBD have been known for a long time, the assumption of the proposed research is to reduce the tension of the masseter muscles, reduce the bruxism index and occlusal strength, as well as reduce pain, from which patients with TMD suffer.
CBD intraoral application therapy seems promising in that field. Patients attending The Department of TMD in Zabrze, Polska will be randomly divided into two groups: experimental and placebo. sEMG activity values will be compared during 14 and 30 days therapy with polymers. the efficacy of the cannabis cream used in the study. Positive results will confirm the efficacy of CBD relaxing properties used in the study, compared to placebo.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
- Patient agreement to participate into the research study
- Age ≥18 and ≤ 60
- Good general health,
- Temporomandibular disorder-positive RDC/TMD examination for group Ia and Ib
- Presence of all teeth (with the exception of the third molars)
- Cannabis cream/ placebo cream allergy
- Hypersensitivity to substances to be used in the study
- Wounds intra oral cavity
- Addiction to cannabis
- Patients being treated with analgesic drugs and/or drugs that affect muscle function
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 10 % polymers with CBD application 10% polymer gel with CBD application Bilateral application of 10% polymer gel with CBD intraorally, on the masseter muscle 5 % polymers with CBD application 5% polymer gel with CBD application Bilateral application of 5% polymer gel with CBD intraorally, on the masseter muscle Placebo group Placebo intervention Application of polymers without CBD on the masseter muscles, bilaterally
- Primary Outcome Measures
Name Time Method Change in masseter muscle electromyographic activity- sEMG examination 30 days Change in masseter muscle electromyographic activity-sEMG examination
Orofacial pain changes 30 days Changes of felt pain recorded by means of VAS scale
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of TMD
🇵🇱Zabrze, Poland